Control of the cell cycle by mRNA degradation.
通过 mRNA 降解控制细胞周期。
基本信息
- 批准号:6844873
- 负责人:
- 金额:$ 27.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-02-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:biotransformationcell cyclechemical cleavagecyclinsendoribonucleasesenzyme activityenzyme substrate complexgene deletion mutationgene expressiongenetic regulatory elementgenetic transcriptiongenomeimmunoprecipitationmessenger RNAmolecular cloningnucleic acid purificationnucleic acid sequenceposttranslational modificationsprotein localizationprotein quantitation /detectionribonucleoproteins
项目摘要
DESCRIPTION (provided by applicant): In recent years a tremendous amount of excitement has surrounded the finding that regulated proteolysis is intricately involved in controlling the cell cycle in yeast and mammals. We have found that regulated ribonuclease digestion also plays a crucial part in controlling the cell cycle in yeast. The major objective for this proposal is to determine the sites, mechanism and regulation of mRNA destabilization by the ribonucleoprotein endoribonuclease RNase MRP in late telophase of the cell division cycle. We have discovered that mutations of different components of the RNase MRP enzyme complex lead to a cell division cycle (CDC) arrest. Divided nuclei and an elongated spindle characterize this late cell cycle arrest, in which cells fail to disassemble their spindle or to undergo cytokinesis. This M to G1 arrest is classically defined by the CDC5, DBF2 group of mutations. These M to G1 mutants lead to the inability to turn off the Clb1&2/Cdc28 cyclin/kinase. Inactivation of the kinase is required for disassembly of the spindle, cytokinesis and the ability to enter G1. Results indicate that the cell division cycle arrest in RNase MRP mutants is the result of a failure to rapidly degrade the CLB2 mRNA. Increased CLB2 mRNA leads to increased CIb2 protein, associated kinase activity and cell cycle arrest. The specific goals during the project period will include characterizing the pathway of CLB2 mRNA degradation and determining direct targets of RNase MRP in addition to CLB2 mRNA. Genome technology will be used to identify all of the potential RNase MRP substrates in a cell. A series of biochemical and genetic analyses will identify instability elements and the direct sites of RNase MRP action. Lastly, we will investigate the regulation of RNase MRP during the cell cycle and determine the means of that regulation. The significance of the role of RNase MRP in the M to G1 transition cannot be overstated. Regulated degradation of specific mRNAs may play as large a part in cell cycle control as regulated proteolysis. Many of these late acting genes have human homologues (PTEN/MMAC1, PIk, Polo, p55CDC) that are intimately involved in regulating the cell cycle and cell proliferation. Humans also have an RNase MRP complex with RNA and protein subunits similar to the yeast enzyme. Mutations in human RNase MRP cause a pleotropic disease, Cartilage Hair Hypoplasia. The manifestations of this disease are caused by a general cell proliferation defect, similar to what we see in yeast. This will allow us to use a simple genetic model system to lend insights into human disease.
描述(由申请人提供):近年来,大量令人兴奋的发现围绕着受调节的蛋白水解复杂地参与控制酵母和哺乳动物的细胞周期。我们已经发现,受调节的核糖核酸酶消化在控制酵母细胞周期中也起着至关重要的作用。该建议的主要目的是确定在细胞分裂周期末期由核糖核蛋白内切核糖核酸酶RNase MRP引起的mRNA不稳定的位点、机制和调节。我们已经发现,RNase MRP酶复合物的不同组分的突变导致细胞分裂周期(CDC)停滞。分裂的细胞核和细长的纺锤体是这种晚期细胞周期停滞的特征,在这种细胞周期停滞中,细胞无法分解其纺锤体或进行胞质分裂。这种从M到G1的停滞通常由CDC 5、DBF 2突变组定义。这些M到G1突变体导致不能关闭Clb1&2/Cdc 28细胞周期蛋白/激酶。激酶的失活是纺锤体解体、胞质分裂和进入G1期的能力所必需的。结果表明,RNase MRP突变体的细胞分裂周期停滞是未能快速降解CLB 2 mRNA的结果。CLB 2 mRNA的增加导致Cib 2蛋白、相关激酶活性和细胞周期停滞的增加。项目期间的具体目标将包括表征CLB 2 mRNA降解的途径,并确定除CLB 2 mRNA外的RNase MRP的直接靶点。基因组技术将用于鉴定细胞中所有潜在的RNase MRP底物。一系列生化和遗传分析将确定不稳定因素和RNase MRP作用的直接位点。最后,我们将研究RNase MRP在细胞周期中的调节,并确定该调节的方法。RNase MRP在M到G1过渡中的作用的重要性不能被夸大。特定mRNA的调节降解在细胞周期控制中可能与调节蛋白水解一样重要。这些迟发作用基因中的许多具有与调节细胞周期和细胞增殖密切相关的人类同源物(PTEN/MMAC 1、PIk、波罗、p55 CDC)。人类也有一个RNase MRP复合体,其RNA和蛋白质亚基类似于酵母酶。人核糖核酸酶MRP的突变导致一种多效性疾病,即软骨毛发发育不全。这种疾病的表现是由一般细胞增殖缺陷引起的,类似于我们在酵母中看到的。这将使我们能够使用一个简单的遗传模型系统来深入了解人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK E SCHMITT其他文献
MARK E SCHMITT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK E SCHMITT', 18)}}的其他基金
Control of the cell cycle by mRNA degradation
通过 mRNA 降解控制细胞周期
- 批准号:
7585209 - 财政年份:2003
- 资助金额:
$ 27.36万 - 项目类别:
Control of the cell cycle by mRNA degradation.
通过 mRNA 降解控制细胞周期。
- 批准号:
6698098 - 财政年份:2003
- 资助金额:
$ 27.36万 - 项目类别:
Control of the cell cycle by mRNA degradation.
通过 mRNA 降解控制细胞周期。
- 批准号:
7007265 - 财政年份:2003
- 资助金额:
$ 27.36万 - 项目类别:
Control of the cell cycle by mRNA degradation
通过 mRNA 降解控制细胞周期
- 批准号:
8016705 - 财政年份:2003
- 资助金额:
$ 27.36万 - 项目类别:
Control of the cell cycle by mRNA degradation.
通过 mRNA 降解控制细胞周期。
- 批准号:
6573711 - 财政年份:2003
- 资助金额:
$ 27.36万 - 项目类别:
相似海外基金
Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission
研究泛素化调节的细胞周期事件支撑疟疾传播
- 批准号:
MR/Y013174/1 - 财政年份:2024
- 资助金额:
$ 27.36万 - 项目类别:
Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
- 批准号:
MR/Y01264X/1 - 财政年份:2024
- 资助金额:
$ 27.36万 - 项目类别:
Research Grant
Conference: FASEB Yeast Chromosome and Cell Cycle Conference 2024
会议:2024 年 FASEB 酵母染色体和细胞周期会议
- 批准号:
2403471 - 财政年份:2024
- 资助金额:
$ 27.36万 - 项目类别:
Standard Grant
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Fellowship
Developmental regulation of the cell cycle machinery
细胞周期机制的发育调控
- 批准号:
10714634 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Cell cycle control of cell polarity and fate in epidermal morphogenesis
表皮形态发生中细胞极性和命运的细胞周期控制
- 批准号:
10608036 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Cell cycle-dependent dynein adaptor switching
细胞周期依赖性动力蛋白适配器转换
- 批准号:
23KF0285 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Regulation of Cell Cycle progression by the nuclear envelope
核膜对细胞周期进程的调节
- 批准号:
10659597 - 财政年份:2023
- 资助金额:
$ 27.36万 - 项目类别:














{{item.name}}会员




